These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11952031)

  • 1. Guidelines for laboratory test result reporting of human immunodeficiency virus type 1 ribonucleic acid determination. Recommendations from a CDC working group. Centers for Disease Control.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2001 Nov; 50(RR-20):1-12. PubMed ID: 11952031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the results of the 2010 External Quality Control Program of the Spanish Society of Infectious Diseases and Clinical Microbiology for HIV-1, HCV, and HBV viral loads].
    Orta Mira N; Serrano Mdel R; Martínez JC; Ovies MR; Poveda M; de Gopegui ER; Cardona CG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():8-14. PubMed ID: 22305664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the results of the SEIMC External Quality Control Program for HIV-1 and HCV viral loads. Year 2008].
    Mira NO; Serrano Mdel R; Martínez JC; Ovies MR; Pérez JL; Cardona CG
    Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():7-11. PubMed ID: 20172417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A collaborative study to establish the first National Standard for HIV-1 RNA nucleic acid amplification techniques (NAT) in Taiwan.
    Yang YC; Yang-Chih Shih D; Tsai MH; Cheng CH; Cheng HF; Lo CF; Wang DY
    J Virol Methods; 2013 Aug; 191(2):122-7. PubMed ID: 23608407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would CLSI M53-A have helped in the diagnosis of HIV in Canada? Results of the performance of Canadian laboratories participating in a recent NLHRS proficiency testing panel containing HIV-1 antigen positive (antibody negative) and HIV-2 samples.
    Kadivar K; Malloch L; Adonsou-Hoyi Y; Ng D; Lavoie S; Pulido K; Kim J
    J Clin Virol; 2013 Sep; 58(1):303-5. PubMed ID: 23890809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the quality of HIV-1 viral load testing through a proficiency testing program using dried tube specimens in resource-limited settings.
    Nguyen S; Ramos A; Chang J; Li B; Shanmugam V; Boeras D; Nkengasong JN; Yang C; Ellenberger D
    J Clin Microbiol; 2015 Apr; 53(4):1129-36. PubMed ID: 25609733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study.
    Nowicki MJ; Benning L; Bremer JW; Meyer WA; Hanson C; Brambilla D; Silver S; Kovacs A;
    J Clin Microbiol; 2001 Oct; 39(10):3760-3. PubMed ID: 11574612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.
    Mine M; Bedi K; Maruta T; Madziva D; Tau M; Zana T; Gaolathe T; Moyo S; Seipone K; Ndwapi N; Essex M; Marlink R
    J Virol Methods; 2009 Jul; 159(1):93-7. PubMed ID: 19442851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.
    Alter MJ; Kuhnert WL; Finelli L;
    MMWR Recomm Rep; 2003 Feb; 52(RR-3):1-13, 15; quiz CE1-4. PubMed ID: 12585742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the results of the SEIMC External Quality Control Program for HIV-1 and HCV viral loads, 2007].
    ; Orta Mira N; Guna Serrano Mdel R; Latorre Martínez JC; Ovies MR; Pérez JL; Gimeno Cardona C
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():8-13. PubMed ID: 19100161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of acute infections during HIV testing in North Carolina.
    Pilcher CD; Fiscus SA; Nguyen TQ; Foust E; Wolf L; Williams D; Ashby R; O'Dowd JO; McPherson JT; Stalzer B; Hightow L; Miller WC; Eron JJ; Cohen MS; Leone PA
    N Engl J Med; 2005 May; 352(18):1873-83. PubMed ID: 15872202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1999 Dec; 48(RR-13):1-27, 29-31. PubMed ID: 10632297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a physician survey on ordering viral load testing. Opportunity for laboratory consultation.
    Hofherr LK; Francis DP; Astles JR; Schalla WO
    Arch Pathol Lab Med; 2003 Apr; 127(4):446-50. PubMed ID: 12683872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control.
    Styer LM; Miller TT; Parker MM
    J Clin Virol; 2013 Dec; 58 Suppl 1():e127-33. PubMed ID: 24342472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.